Avantor (AVTR) Stock Price
Avantor Price
Revenue has compounded at 26.3% per year over the past 10 years to 6.55 B USD. Earnings per share have grown at 74.2% per year over the last 5 years. Avantor's net margin stands at -8.1%, down from 7.8% several years earlier. Analysts set a median price target of 10.20 USD, implying 32.9% below the current price. Of 26 analysts, 8 rate the stock a buy — an overall Hold consensus. The stock trades about 105% above its 52-week low.
Avantor stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Avantor over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Avantor stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Avantor's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Avantor Price |
|---|---|
| 9/3/2026 | 15.19 USD |
| 9/2/2026 | 14.65 USD |
| 9/1/2026 | 14.20 USD |
| 8/31/2026 | 14.54 USD |
| 8/30/2026 | 14.42 USD |
| 8/28/2026 | 14.52 USD |
| 8/27/2026 | 14.60 USD |
| 8/26/2026 | 14.50 USD |
| 8/25/2026 | 14.42 USD |
| 8/24/2026 | 14.24 USD |
| 8/21/2026 | 14.46 USD |
| 8/20/2026 | 14.25 USD |
| 8/19/2026 | 14.00 USD |
| 8/18/2026 | 13.44 USD |
| 8/14/2026 | 13.66 USD |
| 8/13/2026 | 13.85 USD |
| 8/12/2026 | 13.69 USD |
| 8/10/2026 | 13.69 USD |
| 8/7/2026 | 13.59 USD |
| 8/6/2026 | 13.18 USD |
| 8/5/2026 | 13.41 USD |
| 8/4/2026 | 13.57 USD |
| 8/3/2026 | 13.67 USD |
| 7/31/2026 | 13.78 USD |
| 7/30/2026 | 13.86 USD |
| 7/29/2026 | 13.67 USD |
| 7/27/2026 | 11.81 USD |
| 7/23/2026 | 11.35 USD |
| 7/22/2026 | 10.95 USD |
| 7/21/2026 | 10.99 USD |
Avantor Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Avantor Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEB USD |
| EBITB USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | 2030e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.64 | 0.69 | 1.25 | 5.86 | 6.04 | 6.39 | 7.39 | 4.91 | 6.97 | 6.78 | 6.55 | 6.59 | 6.75 | 6.99 | 7.25 | 7.54 |
| – | 8.65 | 80.46 | 370.25 | 3.00 | 5.84 | 15.53 | -33.54 | 41.92 | -2.64 | -3.41 | 0.63 | 2.37 | 3.50 | 3.84 | 3.98 |
| 41.19 | 46.16 | 34.64 | 31.02 | 31.79 | 32.54 | 33.87 | 53.00 | 33.92 | 33.60 | 32.65 | 32.65 | 32.65 | 32.65 | 32.65 | 32.65 |
| 0.26 | 0.32 | 0.43 | 1.82 | 1.92 | 2.08 | 2.50 | 2.60 | 2.36 | 2.28 | 2.14 | 2.15 | 2.20 | 2.28 | 2.37 | 2.46 |
| 0.06 | 0.01 | -0.26 | 0.41 | 0.55 | 0.71 | 0.97 | 1.13 | 0.70 | 1.07 | -0.27 | 0.88 | 0.94 | 1.00 | 1.06 | 1.14 |
| 9.43 | 1.30 | -20.77 | 7.04 | 9.12 | 11.04 | 13.16 | 23.02 | 9.99 | 15.80 | -4.14 | 13.39 | 13.93 | 14.37 | 14.61 | 15.09 |
| 21.00 | -42.00 | -112.00 | -86.00 | 37.00 | 116.00 | 572.00 | 686.00 | 321.00 | 711.00 | -530.00 | 553.00 | 602.00 | 653.00 | 702.00 | 767.00 |
| – | -300.00 | 166.67 | -23.21 | -143.02 | 213.51 | 393.10 | 19.93 | -53.21 | 121.50 | -174.54 | -204.34 | 8.86 | 8.47 | 7.50 | 9.26 |
| 679.30 | 679.30 | 399.87 | 491.30 | 582.10 | 587.10 | 619.00 | 677.10 | 679.20 | 682.70 | 679.30 | 679.30 | 679.30 | 679.30 | 679.30 | 679.30 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Avantor generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Avantor retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Avantor's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Avantor has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Avantor's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Avantor stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Avantor Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Avantor business model & stock analysis
Avantor SWOT Analysis
Strengths
- Avantor Inc has a strong market presence and brand recognition in the scientific research and pharmaceutical industries.
- The company has a wide range of high-quality products and solutions, offering a comprehensive portfolio to its customers.
- Avantor Inc has a well-established global distribution network, enabling it to reach customers in various regions efficiently.
Weaknesses
- Avantor Inc heavily relies on a few key customers, which may expose the company to risks if those customers reduce their orders or switch to competitors.
- The company has a complex supply chain, involving multiple suppliers and logistics, which can lead to challenges in managing inventory and timely order fulfillment.
- Avantor Inc's high dependence on raw materials and supplies from external sources exposes it to potential disruptions in the supply chain.
Opportunities
- Growing demand for scientific research and advancements in the pharmaceutical industry provide opportunities for Avantor Inc to expand its customer base and increase sales.
- The company can capitalize on emerging markets, such as Asia-Pacific, where there is increasing focus on research and development in various industries.
- Avantor Inc can explore strategic partnerships or acquisitions to enhance its product offerings and expand its market reach.
Threats
- Intense competition in the scientific research and pharmaceutical industries poses a threat to Avantor Inc's market share and profitability.
- Changes in government regulations and policies related to the research and pharmaceutical sectors can impact the company's operations and profitability.
- Economic downturns or financial instability in key markets may affect customer spending and demand for Avantor Inc's products.
Avantor Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
Avantor Segments
Avantor Revenue by Segment (1/4)
3 Years
5 Years
Max
Details
Avantor Revenue by Segment (2/4)
3 Years
5 Years
Max
Details
Avantor Revenue by Segment (3/4)
3 Years
5 Years
Max
Details
Avantor Revenue by Segment (4/4)
3 Years
5 Years
Max
Details
Avantor Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Avantor historical P/E ratio, EBIT multiple, and P/S ratio
Avantor annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Avantor shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Avantor forecasts and price targets in September 2026
Analyst Price Targets 2026Avantor Analyst Rating Actions
| Date | Firm | Action | Rating | Reliability |
|---|---|---|---|---|
| 7/30/2026 | Maintained | Overweight | 55 | |
| 7/30/2026 | Maintained | Hold | 56 | |
| 7/30/2026 | Maintained | Sector Perform | 49 | |
| 7/30/2026 | Maintained | Equal Weight | 51 | |
| 7/30/2026 | Maintained | In Line | 62 | |
| 7/8/2026 | Maintained | Neutral | 48 | |
| 7/6/2026 | Maintained | In Line | 62 | |
| 6/24/2026 | Maintained | Underweight | 57 | |
| 4/30/2026 | Maintained | In Line | 62 | |
| 4/30/2026 | Maintained | Neutral | 48 |
Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.
Avantor Earnings Calls
Avantor Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 7/29/2026 | 0.19USD | - | 1.64 BUSD | - | 2026 Q2 |
| 4/29/2026 | 0.16USD | - | 1.57 BUSD | - | 2026 Q1 |
| 2/11/2026 | 0.22USD | - | 1.67 BUSD | - | 2025 Q4 |
| 4/26/2024 | 0.25USD | - | 1.75 BUSD | - | 2024 Q1 |
| 2/1/2024 | 0.23USD | - | 1.73 BUSD | - | 2023 Q4 |
| 7/26/2023 | 0.37USD | - | 1.92 BUSD | - | 2023 Q2 |
| 4/26/2023 | 0.36USD | - | 1.91 BUSD | - | 2023 Q1 |
| 2/1/2023 | 0.31USD | - | 1.82 BUSD | - | 2022 Q4 |
| 10/28/2022 | 0.34USD | - | 1.88 BUSD | - | 2022 Q3 |
| 7/28/2022 | 0.38USD | - | 2.02 BUSD | - | 2022 Q2 |
EESG©
Eulerpool ESG Scorecard© for the Avantor stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Avantor shareholder structure
| % | Name |
|---|---|
17.54220% | |
17.16347% | |
9.63310% | |
9.48797% | |
7.84739% | |
4.88039% |
Avantor Beneficial Ownership Filings (SEC 13D/G)
| Stake | Holder | Filing |
|---|---|---|
17.20% | SEC ↗ | |
10.20% | SEC ↗ | |
10.20% | SEC ↗ | |
9.00% | SEC ↗ | |
8.70% | SEC ↗ | |
8.26% | SEC ↗ | |
7.10% | SEC ↗ | |
6.50% | SEC ↗ | |
5.70% | SEC ↗ | |
5.29% | SEC ↗ |
Avantor Executives and Management Board
20 members · avg. age 58 · 30 % women
Mr. R. Brent Jones (55)
Chief Financial Officer, Executive Vice President
3.89 M USD
Management
Mr. Benoit Gourdier (54)
Executive Vice President - Bioscience Production
Mr. Claudius Sokenu (57)
Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary
Mr. Emmanuel Ligner (55)
President, Chief Executive Officer, Director · since 2025
Ms. Mary Blenn (53)
Executive Vice President, Chief Operating Officer
Ms. Brittany Hankamer (44)
Chief Human Resources Officer, Executive Vice President
Mr. Christophe Couturier (59)
Executive Vice President, AMEA
Board of Directors
Mr. Gregory Summe (68)
Independent Chairman of the Board
Mr. Joseph Massaro (55)
Independent Director
Dr. Michael Severino (59)
Independent Director
Mr. Juan Andres (60)
Independent Director
Ms. Lan Kang (55)
Independent Director
Dr. John Carethers (61)
Independent Director
Avantor Supply Chain
Avantor Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.89 | 0.88 | 0.97 | ||
| 2 | Deepak Nitrite | 0.23 | 0.35 | 0.90 | |
| 3 | 0.72 | 0.55 | 0.89 | ||
| 4 | -0.32 | -0.04 | 0.82 | ||
| 5 | Sabana Industrial REIT | -0.75 | -0.39 | 0.80 |
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | Qualigen Therapeutics | 0.73 | 0.25 | -0.85 | |
| 2 | 0.86 | 0.35 | -0.80 | ||
| 3 | 0.91 | 0.54 | -0.64 | ||
| 4 | -0.14 | 0.29 | -0.58 | ||
| 5 | 0.89 | 0.33 | 0.20 |
Frequently asked questions about Avantor
Avantor Inc. operates as a global provider of products and services for customers in the life sciences and advanced technologies industries. The company's business model focuses on offering a comprehensive range of high-quality products, including chemicals, bio-reagents, consumables, equipment, instruments, and more. Avantor serves diverse markets such as pharmaceuticals, biotechnology, healthcare, diagnostics, academia, research, and electronics. With a strong emphasis on innovation, Avantor strives to deliver customized solutions, reliable support, and efficient procurement processes to its customers worldwide. Avantor's business model revolves around enabling scientific research and technological advancements through its extensive product offerings and industry expertise.
Avantor Inc is primarily active in the life sciences and advanced technology industries.
The main competitors of Avantor Inc in the market include Thermo Fisher Scientific, Merck KGaA, and Sigma-Aldrich.
Avantor Inc is a global provider of mission-critical products and services to customers in the life sciences, advanced technologies, and applied materials industries. Founded in 1904 as J.T. Baker Chemical Company, Avantor has a rich history of innovation and expertise in producing high-quality substances for laboratory research and manufacturing processes. Over the years, Avantor has expanded its portfolio, acquiring leading companies such as VWR International in 2017. Today, Avantor is recognized as a trusted partner for scientists, researchers, and manufacturers worldwide, offering a vast range of products, including chemicals, equipment, consumables, and tailored solutions. With a commitment to advancing science and improving lives, Avantor continues to drive innovation and provide essential support to various industries.
Some significant milestones achieved by Avantor Inc include its successful initial public offering in 2018, which raised over $2 billion in capital, allowing the company to strengthen its position in the life sciences and advanced technologies industries. Furthermore, Avantor expanded its global presence through strategic acquisitions, such as the acquisition of VWR Corporation in 2017, which greatly expanded its product and service offerings. Avantor's commitment to innovation led to the development of new solutions and technologies, including the launch of its Raman spectroscopy system. With these achievements, Avantor Inc has solidified its reputation as a leading provider of high-quality products and services to customers worldwide.
Avantor Inc is primarily present in various countries and regions across the globe. With a strong global footprint, the company operates in North America, Europe, Asia-Pacific, and Latin America. Avantor Inc has established a significant presence in countries like the United States, Canada, Germany, France, China, and Brazil, among others. This broad geographical reach enables Avantor Inc to serve diverse markets and deliver its innovative products and solutions to customers worldwide.
Avantor Inc represents a strong set of values and a positive corporate philosophy. The company believes in fostering innovation, driving customer success, and maintaining the highest level of integrity in all business practices. Avantor is committed to providing high-quality products and services that meet customer needs effectively. With a focus on sustainability, Avantor strives to make a positive impact on the environment and communities it operates in. By prioritizing collaboration, teamwork, and diversity, Avantor ensures a supportive and inclusive workplace for its employees. These values and corporate philosophy guide Avantor in delivering exceptional solutions and contributing to the overall success of its stakeholders.
Analysts currently set an average price target of 10.99 USD for the Avantor stock (median: 10.20 USD), implying -26.6 % versus the latest price. The consensus is based on 26 analyst ratings.
26 analysts currently rate the Avantor stock: 8 recommend buying, 16 holding and 2 selling. For 2026, analysts expect Avantor to generate revenue of 6.59 B USD and earnings per share of 0.82 USD.
Converted at the current exchange rate, the Avantor share trades at 13.08 EUR (15.19 USD).
The Avantor share (AVTR) is listed on 6 stock exchanges, including: NYSE (AVTR-PA), Frankfurt (AVG.F), München (AVG.MU), Düsseldorf (AVG.DU), SIX (Zürich) (AVG.SW), Wien (AVTR.VI).
Avantor Inc is a diversified American company specializing in providing product solutions and services for customers in the fields of life sciences, pharmaceuticals, healthcare, high technology, and related industries. The company's business model is based on a wide range of products and a strong service offering, allowing it to have a global presence in various industries and markets. The company is divided into three business segments: Life Sciences, Advanced Technology Solutions, and Applied Materials. The Life Sciences segment offers a comprehensive range of products, including laboratory chemicals, consumables, cell and gene therapy products, and bioreactors and systems. These products are used in research facilities, diagnostic laboratories, biopharmaceutical companies, hospitals, and other institutions. The Advanced Technology Solutions segment provides high-quality chemical and microelectronic materials, as well as specialty chemicals and gases for semiconductor production, the electronics industry, and solar cell production. The company also produces and distributes custom chemicals tailored to the specific requirements of customers. The Applied Materials segment offers innovative advancements in material science and a wide range of products and services, including consumables, fermentation processes, bioreactor solutions, liquid distribution systems, dispensing and filling systems, configuration and detection devices, and so on. Avantor is known for its outstanding customer and product portfolio. The company has a strong presence in the United States, Europe, and Asia, operating in over 30 countries. Through acquisitions and partnerships, the company has expanded its presence in various industries. In a short period of time, the company has gained the position of a leading supplier in the life sciences and related industries. From a customer perspective, the company has a strong customer relationship management program based on its industry-leading services. The company strives to pursue a customer-oriented mindset and flexible business strategy to satisfy customer needs. The company also supports customers in technical and scientific matters with tailored solutions. Avantor's business model is designed for high product quality, customer-oriented services, and a strong presence in various industries. The success of the company is based on strong innovation, a wide range of products, strong partnerships, and flexible business strategies. As a leading company in the life sciences and related industries, Avantor is expected to continue growing strongly in the coming years.
The expected revenue of Avantor is 6.59 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Avantor is 553.79 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Avantor is currently 18.63. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Avantor stock.
The price-to-sales ratio (P/S) of Avantor is currently 1.56. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Avantor stock.
The Eulerpool Quality Score for Avantor is 3/10.
The ISIN of Avantor is US05352A1007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Avantor is A2PJN6. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Avantor is AVTR. The ticker symbol is used to trade Avantor shares on the stock exchange.
Avantor paid dividends every year for the past 0 years.
Avantor is assigned to the 'Health' sector.
The dividends of Avantor are distributed in USD.
Avantor stock
Avantor Peer Group
Avantor Ticker
Avantor FIGI
All fundamentals and in-depth analysis of Avantor
Our stock analysis for Avantor stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Avantor. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.